City Therapeutics trades 8.5% above its previous close
- Insider
- ARCH Venture Partners XII
- Role
- 10% owner
- Company
- City Therapeutics (CTY)
- Transaction
- Buy
- Shares
- 170,000
- Amount
- $3.1M
- Price per share
- $18.00
- Trade date
- Oct 19, 2026
- Filed
- Oct 19, 2026, 0 days after the trade
- Source
- SEC Form 4 ↗
City Therapeutics traded at $18.46 at 10:29 ET today, 8.5% above the previous close of $17.01. The price is delayed by 15 to 20 minutes.
ARCH Venture Partners XII, a 10% owner, bought 170,000 shares at $18.00 on October 19, 2026. Director Robert Nelsen, also a 10% owner, disclosed a purchase of 170,000 shares at $18.00 on the same day.
The first close after the purchase was $20.83 on Oct 20, 2026. Against that close the share is down 11.4%.
CTY −6.2% on the day, close Nov 16
Today+8.5%At 10:29 ET, delayed
Price$18.46Previous close $17.01
Disclosed buys2In the last 90 days
Since purchase−11.4%ARCH Venture Partners XII, Oct 19